Status:

RECRUITING

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Lead Sponsor:

Fudan University

Collaborating Sponsors:

Peking Union Medical College Hospital

Shanxi Province Cancer Hospital

Conditions:

Advanced Thyroid Cancer Patients Who Received Target Therapy

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

This is a retrospective and prospective real-world clinical study of molecular typing in the treatment of advanced thyroid cancer. The retrospective study : Patients with advanced thyroid cancer who ...

Detailed Description

see:Arms and Interventions

Eligibility Criteria

Inclusion

  • Patients volunteered to participate in this study and signed informed consent;
  • Each center can be enrolled in patients who meet the age of their own practice range, regardless of gender ;
  • Histologically diagnosed locally advanced or recurrent / metastatic thyroid cancer that cannot undergo radical surgery meets one of the following requirements:
  • Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC);
  • Differentiated thyroid carcinoma not suitable for iodine therapy;
  • Medullary thyroid carcinoma (MTC);
  • poorly differentiated thyroid cancer (PDTC) or anaplastic thyroid cancer (ATC);
  • Thyroid-related pathogenic or therapeutic target gene detection was performed before enrollment.

Exclusion

  • Patients who are participating in clinical trials of other drugs;
  • There is evidence that the patients are pregnant or lactating;
  • Other situations that are not suitable for inclusion in this study.

Key Trial Info

Start Date :

January 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT06195228

Start Date

January 1 2020

End Date

December 31 2028

Last Update

August 14 2025

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Fujian Cancer Hospital

Fuzhou, Fujian, China

2

Henan Cancer Hospital

Zhengzhou, Henan, China

3

Union Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan, Hubei, China

4

Caixia Liu

Hohhot, Inner Mongolia, China, 010000